Defining the transcriptome of PIK3CA-altered cells in a human capillary malformation using single cell long-read sequencing

Michelle A. Wedemeyer,Tianli Ding,Elizabeth A. R. Garfinkle,Jesse J. Westfall,Jaye B. Navarro,Maria Elena Hernandez Gonzalez,Elizabeth A. Varga,Patricia Witman,Elaine R. Mardis,Catherine E. Cottrell,Anthony R. Miller,Katherine E. Miller

DOI: https://doi.org/10.1038/s41598-024-72167-8

IF: 4.6

2024-10-27

Scientific Reports

Abstract:PIK3CA -related overgrowth spectrum (PROS) disorders are caused by somatic mosaic variants that result in constitutive activation of the phosphatidylinositol-3-kinase/AKT/mTOR pathway. Promising responses to molecularly targeted therapy have been reported, although identification of an appropriate agent can be hampered by the mosaic nature and corresponding low variant allele frequency of the causal variant. Moreover, our understanding of the molecular consequences of these variants—for example how they affect gene expression profiles—remains limited. Here we describe in vitro expansion of a human capillary malformation followed by molecular characterization using exome sequencing, single cell gene expression, and targeted long-read single cell RNA-sequencing in a patient with clinical features consistent with Megalencephaly-Capillary Malformation Syndrome (MCAP, a PROS condition). These approaches identified a targetable PIK3CA variant with expression restricted to PAX3+ fibroblast and undifferentiated keratinocyte populations. This study highlights the innovative combination of next-generation single cell sequencing methods to better understand unique transcriptomic profiles and cell types associated with MCAP, revealing molecular intricacies of this genetic syndrome.

multidisciplinary sciences